HLS Therapeutics Announces Fiscal 2023 Financial Results -March 14, 2024 at 0631 am EDT - Marketscreener.com
| HLTRF Stock | USD 2.40 0.04 1.64% |
Roughly 62% of HLS Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading HLS Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with HLS Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use HLS Therapeutics stock news signals to limit their universe of possible portfolio assets.
HLS Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of HLS daily returns and investor perception about the current price of HLS Therapeutics as well as its diversification or hedging effects on your existing portfolios.
HLS |
HLS Therapeutics Announces Fiscal 2023 Financial Results -March 14, 2024 at 0631 am EDT Marketscreener.com
Read at news.google.com
 |
HLS Therapeutics Fundamental Analysis
We analyze HLS Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HLS Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HLS Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
HLS Therapeutics is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
HLS Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HLS Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of HLS Therapeutics could also be used in its relative valuation, which is a method of valuing HLS Therapeutics by comparing valuation metrics with similar companies.
Peers
HLS Therapeutics Related Equities
| BINP | Bionoid Pharma | 8.00 | ||||
| CRRTF | Crescita Therapeutics | 0.00 | ||||
| KHTRF | Knight Therapeutics | 0.53 | ||||
| LOVFF | Cannara Biotech | 9.09 |
Complementary Tools for HLS Pink Sheet analysis
When running HLS Therapeutics' price analysis, check to measure HLS Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLS Therapeutics is operating at the current time. Most of HLS Therapeutics' value examination focuses on studying past and present price action to predict the probability of HLS Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLS Therapeutics' price. Additionally, you may evaluate how the addition of HLS Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |